Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...
المؤلفون الرئيسيون: | Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2007
|
مواد مشابهة
-
Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
حسب: Roelofs, A, وآخرون
منشور في: (2005) -
APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
حسب: Croucher, P, وآخرون
منشور في: (2002) -
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
حسب: Roelofs, A, وآخرون
منشور في: (2007) -
Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
حسب: Roelofs, A, وآخرون
منشور في: (2006) -
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
حسب: Croucher, P, وآخرون
منشور في: (2003)